[HTML][HTML] Efficacy of cefiderocol-vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant …
Introduction Ventilator-associated pneumonia (VAP) caused by carbapenem-resistant
Acinetobacter baumannii (CRAB) in patients hospitalized in intensive care units (ICUs) is an …
Acinetobacter baumannii (CRAB) in patients hospitalized in intensive care units (ICUs) is an …
Efficacy of cefiderocol-versus colistin-containing regimen for treatment of bacteremic ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter …
A Russo, A Bruni, S Gullì, C Borrazzo… - International Journal …, 2023 - europepmc.org
Methods this was a single-center, observational study conducted from March 2020 to August
2022, including all patients hospitalized consecutively with VAP and concomitant …
2022, including all patients hospitalized consecutively with VAP and concomitant …
Efficacy of cefiderocol-vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter …
A Russo, A Bruni, S Gullì, C Borrazzo, A Quirino… - 2023 - cabidigitallibrary.org
Introduction: Ventilator-associated pneumonia (VAP) caused by carbapenem-resistant
Acinetobacter baumannii (CRAB) in patients hospitalized in intensive care units (ICUs) is an …
Acinetobacter baumannii (CRAB) in patients hospitalized in intensive care units (ICUs) is an …
[HTML][HTML] Efficacy of cefiderocol-vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant …
A Russo, A Bruni, S Gullì, C Borrazzo… - International Journal …, 2023 - ncbi.nlm.nih.gov
Methods This single-centre, observational study was conducted from March 2020 to August
2022, and included all patients hospitalized consecutively with VAP and concomitant …
2022, and included all patients hospitalized consecutively with VAP and concomitant …
[引用][C] EFFICACY OF CEFIDEROCOL-VERSUS COLISTIN-CONTAINING REGIMEN FOR TREATMENT OF BACTEREMIC VENTILATOR-ASSOCIATED PNEUMONIA …
A Russo, A Bruni, S Gullì, C Borrazzo… - INTERNATIONAL …, 2023 - iris.unicz.it
EFFICACY OF CEFIDEROCOL- VERSUS COLISTIN-CONTAINING REGIMEN FOR TREATMENT
OF BACTEREMIC VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY …
OF BACTEREMIC VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY …
Efficacy of cefiderocol-vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter …
A Russo, A Bruni, S Gullì, C Borrazzo… - International …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Ventilator-associated pneumonia (VAP) caused by carbapenem-resistant
Acinetobacter baumannii (CRAB) in patients hospitalized in intensive care units (ICUs) is an …
Acinetobacter baumannii (CRAB) in patients hospitalized in intensive care units (ICUs) is an …
Efficacy of cefiderocol-versus colistin-containing regimen for treatment of bacteremic ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter …
A Russo, A Bruni, S Gullì, C Borrazzo… - International Journal …, 2023 - europepmc.org
Methods this was a single-center, observational study conducted from March 2020 to August
2022, including all patients hospitalized consecutively with VAP and concomitant …
2022, including all patients hospitalized consecutively with VAP and concomitant …